Poging GOUD - Vrij
THE BIG PHARMA OPPORTUNITY
Business Today India
|February 02, 2025
The patent expiry of key drugs in 2025-26 will open up additional market space for Indian manufacturers of generics and biosimilars
A SIGNIFICANT OPPORTUNITY lies ahead for the Indian pharmaceuticals industry in 2025-26. During this period, the patents of 20-25 high-revenue drugs will expire-a situation known as the patent cliff-presenting a big chance for Indian firms to introduce more affordable alternatives, adding to their already impressive supply of over 20% of the world's generic drugs. "India already has a strong position in the global generic drugs market. The patent cliff will further enhance this role," says Rashmi Chaturvedi Upadhyay, Senior Pharma Consultant at Dialectica, an information services firm.
Dit verhaal komt uit de February 02, 2025-editie van Business Today India.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Business Today India
Business Today India
"GIFT LINKED TO THE INDIA GROWTH STORY"
K. Rajaraman, Chairman, IFSCA, throws light on initiatives driving growth, and the vision for IFSC
2 mins
May 24, 2026
Business Today India
"THE IDEA IS TO CATER TO 25-30 MARKETS"
V. Balasubramaniam, MD and CEO, NSE IX, says the exchange is scaling to become a debt and equity platform for companies across Asian, African and smaller European markets
2 mins
May 24, 2026
Business Today India
CRICKET'S NEW GLOBAL ORDER
ONCE THE PLAYGROUND OF BOLLYWOOD CELEBRITIES AND VANITY BUYERS, IPL FRANCHISES HAVE GRADUATED INTO BLUE-CHIP ASSETS, ATTRACTING SOVEREIGN WEALTH, WEALTH FUNDS, COMMANDING RECORD VALUATIONS, AND ANCHORING A CROSS-CONTINENT, YEAR-ROUND CRICKET ECONOMY
11 mins
May 24, 2026
Business Today India
INDIA'S THORIUM BET
INDIA'S PROTOTYPE FAST BREEDER REACTOR HAS ACHIEVED CRITICALITY, ADVANCING THE THREE-STAGE NUCLEAR STRATEGY. IS THE COUNTRY CLOSE TO USING ITS VAST THORIUM RESERVES TO BECOME ATMANIRBHAR IN NUCLEAR POWER GENERATION?
7 mins
May 24, 2026
Business Today India
“Will benefit from consolidation in real estate sector”
Pirojsha Godrej, Chairperson-designate of Godrej Industries Group, on how the group has been delivering 20% sales and earnings growth
6 mins
May 24, 2026
Business Today India
AI IS A LEADERSHIP, NOT A TECHNOLOGY QUESTION
Business consultant, advisor, and author Ram Charan on AI challenges, succession planning, and more
5 mins
May 24, 2026
Business Today India
REIMAGING COAL
COAL CAN BE AS CLEAN AS ANY OTHER ENERGY SOURCE AND MAKE INDIA SELF-RELIANT IN FERTILISER AND OIL & GAS, AS CHINA AND SOUTH AFRICA HAVE PROVED. BUT FOR THAT, THE COUNTRY WILL HAVE TO PUR
5 mins
May 24, 2026
Business Today India
GIFT'S MOMENT OF TRUTH
GIFT CITY IN GUJARAT IS FAST EMERGING AS AHUB FOR CROSS-BORDER CAPITAL. IT IS OPENING NEW DOORS FOR INDIANS AS WELL AS NRIs TO INVEST ACROSS MARKETS. CAN IT COMPETE WITH OTHER REGIONAL OFFSHORE FINANCIAL CENTRES SUCH AS DUBAI?
11 mins
May 24, 2026
Business Today India
AIMING FOR THE SUN
SUN PHARMACEUTICAL INDUSTRIES HAS STRUCK ITS LARGEST GLOBAL DEAL TO ACQUIRE US-BASED ORGANON FOR $11.75 BILLION. THIS DEAL EXPANDS SUN PHARMA'S FOOTPRINT - TO 150 MARKETS. WILL IT PAY OFF?
14 mins
May 24, 2026
Business Today India
THE NEW SPACE ODYSSEY
INDIA'S $13-BILLION SPACETECH SECTOR AIMS TO HIT $40 BILLION BY 2030. BUT WITH JUST 1.3% OF GLOBAL CAPITAL AND NO MAJOR EXITS YET, CAN IT TRULY SCALE?
7 mins
May 24, 2026
Listen
Translate
Change font size